Hexagon Nutrition IPO covered 3.87x on Day 2, retail leads at 5.51x
The ₹139-crore issue from the maker of Pentasure, Obesigo and Pediagold drew 5.51x retail and 5.01x NII demand by Day 2, while QIBs trailed at 0.17x. Priced at ₹42-45 (P/E 15.3x) with ₹41.66 crore anchor book and PAT CAGR of 104.6% over FY23-FY25, SBI Securities tags it a long-term subscribe ahead of June 12 listing.
What happened
Hexagon Nutrition's ₹139-crore IPO subscribed 3.87x on Day 2, led by retail (5.51x) and NII (5.01x). The branded nutrition company behind Pentasure, Obesigo and
Key facts
- 3.87x subscription
- retail 5.51x
- NII 5.01x
- QIB 0.17x
- ₹139 crore issue
- price band ₹42-45
- ₹41.66 crore anchor
- P/E 15.3x
- PAT CAGR 104.6% FY23-FY25
Why this matters
Hexagon's successful ₹139-crore raise at 15.3x P/E sets a useful comp for clinical-nutrition M&A and validates investor appetite for branded specialty-nutrition platforms in India.